ARROW FINANCIAL CORP quarterly report, Q2 FY2012

Arrow Financial Corporation — Q2 2012 Form 10-Q

Reporting period: Quarter and six months ended June 30, 2012. Arrow is a New York bank holding company with banking, insurance, and investment-advisory operations. Dollar amounts below are in millions unless otherwise noted.

Financial results and condition

  • Q2 earnings: Net income was $5.594 million, down 4.4% from $5.849 million; diluted EPS was $0.48 versus $0.50. Return on average assets was 1.13% and return on average equity was 13.22%.
  • First-half earnings: Net income was $10.882 million, down 2.2%; diluted EPS was $0.92 versus $0.95. ROA was 1.11% and ROE was 12.95%.
  • Revenue and margins: Q2 tax-equivalent net interest income declined 1.9% to $15.229 million; net interest margin was 3.26%, down 9 basis points year over year. First-half tax-equivalent net interest income declined 1.6% to $30.507 million and margin fell 8 basis points to 3.29%. Q2 noninterest income rose 9.3% to $6.808 million; first-half noninterest income increased 12.8% to $13.367 million.
  • Expenses and profitability: Q2 noninterest expense increased 3.9% to $12.651 million; first-half expense rose 5.3% to $25.797 million. The reported efficiency ratio was 57.20% for Q2 and 59.74% for the first half, using Arrow’s non-GAAP definition.
  • Cash flow: First-half operating cash flow was $16.736 million versus $24.505 million in 2011; investing cash flow was $5.097 million versus $31.500 million; financing cash outflow was $7.818 million versus $29.764 million. Cash and cash equivalents ended at $57.751 million, up $14.015 million from year-end.
  • Assets, lending, and deposits: Total assets were $1.967 billion, up 3.4% year over year. Loans were $1.147 billion, up 2.4% year over year. Deposits were $1.705 billion, up 10.6% year over year and 3.7% from year-end 2011.
  • Funding and debt: At June 30, short-term repurchase/federal funds borrowings were $16.097 million; FHLB term advances were $30.0 million; and junior subordinated obligations were $20.0 million. FHLB overnight advances had been repaid, and total borrowings were lower than at year-end 2011.
  • Capital and shareholder returns: Stockholders’ equity was $171.940 million. The company and both banks qualified as well-capitalized; Arrow’s Tier 1 leverage, Tier 1 risk-based, and total risk-based capital ratios were 9.09%, 15.08%, and 16.34%. Q2 cash dividend was $0.25 per share; the board declared another $0.25 dividend for Q3. Tangible book value per share was $12.35.

Material changes versus comparable periods

  • Lower asset yields outweighed reduced funding costs: Q2 tax-equivalent earning-asset yield fell 47 basis points year over year, while the cost of interest-bearing liabilities fell 44 basis points. The resulting net interest margin declined.
  • Q2 noninterest income benefited from increased insurance commissions and loan-sale gains, partly offset by lower securities gains. First-half insurance commissions rose 21.8% and loan-sale gains increased to $0.894 million from $0.218 million.
  • Noninterest expense rose, largely reflecting personnel and operating costs at acquired insurance agencies, including the McPhillips Agencies. The lower FDIC assessment partly offset expense growth.
  • Asset quality weakened on several reported measures: nonperforming loans were $7.836 million, or 0.68% of loans, versus 0.52% a year earlier; nonperforming assets were $8.673 million, or 0.44% of assets, versus $5.882 million a year earlier. The allowance was $15.211 million, or 1.33% of loans. First-half net charge-offs remained low at $0.312 million.
  • The balance-sheet securities mix shifted: available-for-sale securities declined to $431.010 million from $556.538 million at year-end, while held-to-maturity securities increased to $252.902 million from $150.688 million, reflecting purchases and portfolio activity.

Outlook, commentary, risks, and unusual items

  • Management gave no formal earnings guidance. It expected continued pressure on net interest margin as higher-yielding assets mature or prepay and replacement yields remain low; it cautioned that net interest income and earnings may not resume growth.
  • Management expected insurance commission income to continue increasing following agency acquisitions. Residential mortgage originations were largely sold to Freddie Mac, supporting loan-sale income but limiting retained mortgage growth.
  • Management described liquidity as strong, citing deposit growth, liquid assets, $109.2 million of unused FHLB borrowing capacity, $255.1 million available through Federal Reserve discount-window collateral, and $30 million of correspondent-bank credit lines. No amounts were drawn on those facilities during the first half.
  • Interest-rate risk is a key exposure. The company’s model estimated that a 200-basis-point rate increase would reduce net interest income by 1.08%, while a modeled decrease in long-term rates would reduce it by 0.45%; management cautioned that these are hypothetical sensitivities, not forecasts.
  • Other risks include economic weakness, credit deterioration, competition, municipal deposit seasonality, regulatory and compliance costs, and proposed Basel III capital rules. Management said current capital ratios exceeded the proposed minimums, including the proposed conservation buffer, if those rules had applied at quarter-end.
  • Unusual item: Arrow reversed its remaining $294,000 pre-tax VISA litigation reserve in Q2, adding about $178,000 after tax, or approximately $0.02 per share. The reversal was based on management’s view that Visa’s escrow fund was substantially sufficient for remaining covered litigation. Arrow assigned no economic value to its remaining Visa Class B shares.
  • The filing reported no material pending legal proceedings beyond routine business litigation and no material changes to previously disclosed risk factors. Interim financial statements were reviewed, not audited; the auditor reported no material modifications it believed necessary.

Important facts for investors to verify

  • Whether margin compression continues and how asset yields and deposit costs reprice.
  • Whether the increase in nonperforming loans and assets persists, and whether the allowance remains adequate.
  • How much reported income depends on securities gains, loan-sale gains, acquired insurance operations, and the VISA reserve reversal.
  • Whether deposit growth—particularly seasonal municipal deposits—remains stable and whether liquidity capacity is available under stress.
  • The final requirements and implementation timeline for proposed capital rules, and their potential effects on capital, dividends, and lending.
  • Whether planned dividends and share repurchases remain consistent with earnings, capital needs, and the company’s outlook.